ALMAY CLEAR COMPLEXION CONCEALER

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ALMAY CLEAR COMPLEXION CONCEALER
Generic name: SALICYLIC ACID
Manufacturer: ALMAY
Product type: HUMAN OTC DRUG
SPL set ID: 2a932c8f-3a48-dfcd-e063-6394a90ac20b
SPL ID: 2a92edc1-04b7-3eda-e063-6294a90ad46d
Version: 1
Effective date: 2024-12-31
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:53:49

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		ALMAY CLEAR COMPLEXION CONCEALER	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		ALMAY	openfda.manufacturer_name
ndc	package	0311-0735-30	openfda.package_ndc
ndc	product	0311-0735	openfda.product_ndc
ndc11	package	00311073530	derived:openfda.package_ndc
spl id		2a92edc1-04b7-3eda-e063-6294a90ad46d	id
spl set id		2a932c8f-3a48-dfcd-e063-6394a90ac20b	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS When using this product • Skin irritation and dryness is more likely to occur if you use another topical acne mediation at the same time. If irritation occurs, only use one topical acne medication at a time. • Avoid contact with eyes. If contact occurs, flush thoroughly with water

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.